All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Potential use of radiolabelled neurotensin in PET imaging and therapy of patients with pancreatic cancer

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F20%3A73604427" target="_blank" >RIV/61989592:15110/20:73604427 - isvavai.cz</a>

  • Result on the web

    <a href="https://www.researchgate.net/publication/339881267_Potential_use_of_radiolabelled_neurotensin_in_PET_imaging_and_therapy_of_patients_with_pancreatic_cancer" target="_blank" >https://www.researchgate.net/publication/339881267_Potential_use_of_radiolabelled_neurotensin_in_PET_imaging_and_therapy_of_patients_with_pancreatic_cancer</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1097/MNM.0000000000001172" target="_blank" >10.1097/MNM.0000000000001172</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Potential use of radiolabelled neurotensin in PET imaging and therapy of patients with pancreatic cancer

  • Original language description

    Pancreatic cancer is the fourth leading cause of cancer-related death in both men and women. Neurotensin receptors are overexpressed in different malignancies, above all pancreatic cancer. On the other hand, neurotensin receptor expression in inflammation is quite low. This fact can probably solve the most important problem of F-FDG PET imaging - distinguishing malignant and inflammatory processes. The first therapeutic injection of radiolabelled neurotensin in human with pancreatic cancer has been successfully performed. Animal experiments are also very close to the first in human injection of radiolabelled neurotensin for diagnostic purposes. The purpose of this article is to provide an overview of radiolabelled neurotensin analogues that can be used in imaging and therapy in patients with pancreatic ductal adenocarcinoma.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30224 - Radiology, nuclear medicine and medical imaging

Result continuities

  • Project

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2020

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    NUCLEAR MEDICINE COMMUNICATIONS

  • ISSN

    0143-3636

  • e-ISSN

  • Volume of the periodical

    41

  • Issue of the periodical within the volume

    5

  • Country of publishing house

    US - UNITED STATES

  • Number of pages

    5

  • Pages from-to

    "411 "- 415

  • UT code for WoS article

    000531338900001

  • EID of the result in the Scopus database

    2-s2.0-85083041368